Literature DB >> 3040912

Stimulation of inositol phosphate production by neurotensin in neuroblastoma N1E115 cells: implication of GTP-binding proteins and relationship with the cyclic GMP response.

S Amar, P Kitabgi, J P Vincent.   

Abstract

The association of neurotensin to its receptor in differentiated neuroblastoma N1E115 cells led to a fast and transitory increase of the intracellular concentration in inositol triphosphate and inositol biphosphate, followed by a slower and more stable increase inositol monophosphate. The action of inositol 1,4,5-triphosphate on digitonin-permeabilized N1E115 cells resulted in a stimulation of cyclic GMP levels that mimicked that induced by neurotensin. Therefore, the cyclic GMP stimulation is probably a consequence of the initial inositol triphosphate formation triggered by neurotensin. Fluoroaluminate ions and pertussis toxin had the capacity to modulate positively and negatively, respectively, the formation of inositol triphosphate induced by neurotensin, indicating that GTP-binding proteins are involved in the regulation of inositol phosphate levels by neurotensin receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040912     DOI: 10.1111/j.1471-4159.1987.tb09986.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Neurotensin receptors: binding properties, transduction pathways, and structure.

Authors:  J P Vincent
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

2.  Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24.

Authors:  C Poinot-Chazel; M Portier; M Bouaboula; N Vita; F Pecceu; D Gully; J G Monroe; J P Maffrand; G Le Fur; P Casellas
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

3.  Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Involvement of a G-protein.

Authors:  J C Bozou; N Rochet; I Magnaldo; J P Vincent; P Kitabgi
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

4.  Characterization of the effect of SR48692 on inositol monophosphate, cyclic GMP and cyclic AMP responses linked to neurotensin receptor activation in neuronal and non-neuronal cells.

Authors:  F Oury-Donat; O Thurneyssen; N Gonalons; P Forgez; D Gully; G Le Fur; P Soubrie
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

5.  Neurotensin regulates growth of human pancreatic cancer.

Authors:  J Ishizuka; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

Review 6.  NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.

Authors:  Daniel Martinez-Fong; Michael J Bannon; Louis-Eric Trudeau; Juan A Gonzalez-Barrios; Martha L Arango-Rodriguez; Nancy G Hernandez-Chan; David Reyes-Corona; Juan Armendáriz-Borunda; Ivan Navarro-Quiroga
Journal:  Nanomedicine       Date:  2012-03-07       Impact factor: 5.307

7.  Molecular characterization of Thy1 expressing fear-inhibiting neurons within the basolateral amygdala.

Authors:  Kenneth M McCullough; Dennis Choi; Jidong Guo; Kelsey Zimmerman; Jordan Walton; Donald G Rainnie; Kerry J Ressler
Journal:  Nat Commun       Date:  2016-10-21       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.